Drug protein interactome

Show results for

Unknown (360)
Proteomics (111)
Transcriptomics (28)
Genomics (13)
Other (3)
Multiomics (1)
Metabolomics (1)

Organisms

Allexis (76)
Arabidopsis thaliana (76)
Entamoeba histolytica HM-1:IMSS-A (76)
Escherichia coli (76)
Homo sapiens (76)
Listeria monocytogenes (76)
Medicago truncatula (76)
Mus musculus (76)
Rattus norvegicus (76)
Saccharomyces cerevisiae (76)
Schizosaccharomyces pombe (76)
Shigella (76)
Shigella flexneri (76)
Sinorhizobium meliloti BL225C (76)
Solanum tuberosum (76)
Staphylococcus aureus (76)
Sus scrofa domesticus (76)
Zea mays (76)
Bos taurus (75)
Callinectes sapidus (75)
Drosophila melanogaster (75)
Entamoeba histolytica (75)
Leishmania major strain Friedlin (75)
Homo sapiens (42)
Mus musculus (6)
Saccharomyces cerevisiae (3)
Drosophila melanogaster (1)
Equus caballus (1)
synthetic construct (1)
Vaccinia virus WR (1)

Organisms

Homo sapiens (7)
Saccharomyces cerevisiae (1)
Equus caballus (1)

Repository

pride (76)
biostudies-arrayexpress (24)
MassIVE (15)
jPOST (12)
ENA (11)
geo (8)
iProX (8)
GPMDB (1)
MetaboLights (1)

Tissue

Cell culture (34)
Epithelial cell (12)
Permanent cell line cell (11)
Blood (3)
Early embryonic cell (3)
Cell line cell (2)
Colon (2)
Embryonic stem cell (2)
Heart (2)
Kidney (2)
B cell (1)
Blood cell (1)
Blood serum (1)
Bone marrow (1)
Brain (1)
Cell line cell culturing (1)
Cervical cancer cell line (1)
Embryonic kidney cell line (1)
Fibroblast (1)
HEK-293 cell (1)
Kidney cell (1)
Kidney epithelium (1)
Leukocyte (1)
Malignant cell (1)
Melanocyte (1)
Muscle (1)
Myoblast (1)
Pancreas (1)
Whole body (1)

Disease

Trypanosomiasis (9)
Breast cancer (2)
Cervix carcinoma (2)
Glioblastoma (2)
Not Available (1)
Acute leukemia (1)
Cancer (1)
Disease free (1)
Fabry disease (1)
Heart conduction disease (1)
Kidney cancer (1)
Lymphoma (1)
Melanoma (1)
Osteosarcoma (1)
Pancreatitis (1)
Plasmodium falciparum malaria (1)
Skin melanoma (1)
Sleeping sickness (1)
Squamous cell carcinoma (1)
Tauopathy (1)

Technology Type

Mass Spectrometry (76)
Affinity purification coupled with mass spectrometry proteomics (38)
Shotgun proteomics (21)
Bottom-up proteomics (8)
Data-dependent acquisition (7)
Chemical cross-linking coupled with mass spectrometry proteomics (4)
Data-independent acquisition (4)
Gel-based experiment (2)
Mass spectrometry (1)
Top-down proteomics (1)

Instrument Platform

Orbitrap Fusion Lumos (4)
Q Exactive (3)
Q Exactive HF (2)
TripleTOF 5600 (2)
Illumina NovaSeq X (1)
NextSeq 2000 (1)
Illumina HiSeq 2500 (1)
Illumina NovaSeq 6000 (1)
Illumina HiSeq 4000 (1)
Instrument (1)
LTQ Orbitrap Discovery (1)
LTQ Orbitrap Velos (1)
Orbitrap Exploris 480 (1)
Orbitrap Fusion (1)
Orbitrap Fusion Tribrid mass spectrometer (1)
Q Exactive Plus (1)
TimsTOF Pro (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2025 (30)
2023 (15)
2022 (12)
2020 (12)
2024 (12)
2021 (11)
2019 (10)
2015 (9)
2026 (7)
2018 (5)
2017 (5)
2014 (4)
2012 (4)
2013 (3)
2008 (2)
2010 (1)
2007 (1)
2016 (1)

First Public Date

2020 (3)
2026 (2)
2024 (1)
2022 (1)
2021 (1)
2019 (1)
2018 (1)
2015 (1)

Modification

2x(15)N labeled L-lysine (2)
4-tetrahydrothiazine-3-carboxylic acid (1)
4x(15)N labeled L-arginine (1)
N6 (1)

Study type

Transcription profiling by array (12)
RNA-seq of coding RNA (4)
One-color microarray (1)
Cell line - One-color microarray (1)
Comparative genomic hybridization by array (1)
RIP-seq (1)
ChIP-seq (1)
RNA-seq of coding RNA from single cells (1)
Methylation profiling by high throughput sequencing (1)
RNA-seq of non coding RNA (1)

Release Date

2022 (46)
2021 (44)
2020 (40)
2023 (31)
2024 (30)
2025 (26)
2019 (26)
2018 (22)
2015 (19)
2016 (19)
2017 (18)
2014 (16)
2013 (13)
2026 (9)
2012 (7)
2010 (6)
2008 (4)
2011 (3)
2009 (3)
2007 (2)

Lab affiliation

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA (7)
Novartis Inst. for BioMedical Research (3)
Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA (2)
Head of Drug Discovery and Evaluation Charles University in Prague, BIOCEV Průmyslová 595 252 50 Vestec Czech Republic (2)
Regional Centre for Biotechnology, 3rd milestone Gurgaon Faridabad Expressway 121001, Faridabad INDIA, 0129-2848820, 0129-2848800 (2)
THSTI - National Chair and Head, Drug Discovery Research Centre Translational Health Science and Technology Institute, Faridabad, INDIA (2)
Associate Professor, Department of Chemistry and Biochemistry, University of Texas At Arlington (1)
Biochemistry and Molecular Biology, University of British Columbia, Canada (1)
Biological Chemistry and Drug Discovery, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee (1)
Biologie des interactions hôte-parasite Institut Pasteur (1)
Biomolecular Mass Spectrometry and Proteomics Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences Utrecht University Padualaan 8 3584 CH Utrecht The Netherlands, Janssen Infectious Diseases and Vaccines, Crucell Holland B.V., Leiden, the Netherlands (1)
Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH Utrecht, the Netherlands. Netherlands Proteomics Centre, Padualaan 8, 3584 CH Utrecht, the Netherlands (1)
Cancer Science Institute of Singapore (CSI), National University of Singapore (NUS) (1)
Cardiovascular Research Institute, Baylor College of Medicine, Houston, TX, USA (1)
Chair of Proteomics and Bioanalytics, Technical University of Munich (TUM), 85354 Freising, Germany (1)
Chair, Quantitative Proteomics Director, Proteome Center Tuebingen Interfaculty Institute for Cell Biology University of Tuebingen Auf der Morgenstelle 15 72076 Tuebingen Germany (1)
Charles University in Prague Faculty of Science, Department of Parasitology BIOCEV Průmyslová 595 252 50 Vestec Czech Republic (1)
Charles University in Prague, BIOCEV Průmyslová 595 252 50 Vestec Czech Republic (1)
Cleveland Clinic (1)
Departament of Experimental and Health Sciences, Pompeu Fabra University, Barcelona, Spain (1)
Department of Biochemistry, University of Oxford, UK (1)
Department of Biology, York University, Toronto, ON M3J 1P3, Canada (1)
Department of Genome Sciences, University of Washington (1)
Department of Immunology and Microbiology Institute of Biomedicine Sahlgrenska Academy University of Gothenburg (1)
Department of Nuclear Medicine and Radiobiology Faculty of Medicine and Health Sciences Université de Sherbrooke Sherbrooke, Quebec, Canada (1)
Department of Pathology and Cancer Center, Stony Brook University, Stony Brook, NY 11794 (1)
Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, United States (1)
Department of Pharmacy, University of Salerno, 84084 Fisciano, Italy (1)
Division of Chemical Biology and Medicinal Chemistry, Center for Integrative Chemical Biology and Drug Discovery, UNC Eshelman School of Pharmacy Lineberger Comprehensive Cancer Center Department of Biochemistry and Biophysics University of North Carolina, Chapel Hill, NC, USA (1)
Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands (1)

Previous page
1 / 52
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 52
Next page

Sort by:

Relevance

Page size

An integrative in silico approach for discovering candidates for drug-targetable protein-protein interactions in interactome data.

Not available

S-EPMC2045083 | biostudies-literature

INTEDE: interactome of drug-metabolizing enzymes.

Not available

S-EPMC7779056 | biostudies-literature

DDI-CPI, a server that predicts drug-drug interactions through implementing the chemical-protein interactome.

Not available

S-EPMC4086096 | biostudies-literature

Extracellular Proximity Labeling Reveals an Expanded Interactome for the Matrisome Protein TIMP2.

Not available

S-EPMC10836090 | biostudies-literature

Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma

LMO2 regulates gene expression facilitating the formation of multipartite DNA-binding complexes. In B cells, LMO2 is specifically up-regulated in the Germinal Center (GC) reaction and is expressed in GC-derived non-Hodgkin’s lymphomas. LMO2 is one of the most powerful prognostic indicators in DLBCL ...

ORGANISM(S): Homo sapiens

2012-07-12 | E-GEOD-34576 | biostudies-arrayexpress

A multiplexed assay to identify condition-dependent changes in protein-protein interactions

Testing the effect of 80 small molecules on the interaction between 250 protein pairs

ORGANISM(S): Saccharomyces cerevisiae

2012-04-02 | E-MEXP-3467 | biostudies-arrayexpress

DPDR-CPI, a server that predicts Drug Positioning and Drug Repositioning via Chemical-Protein Interactome.

Not available

S-EPMC5090963 | biostudies-literature

Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing.

Not available

S-EPMC7360763 | biostudies-literature